| Dr Kenneth Kyle Cloninger, MD | |
|
808 Schenck St, Shelby, NC 28150-3934 | |
| (704) 480-9344 | |
| (704) 484-3260 |
| Full Name | Dr Kenneth Kyle Cloninger |
|---|---|
| Gender | Male |
| Speciality | |
| Experience | Years |
| Location | 808 Schenck St, Shelby, North Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265411086 | NPI | - | NPPES |
| 8923031 | Medicaid | NC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 9500537 (North Carolina) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kenneth Kyle Cloninger, MD 808 Schenck St, Cleco Primary Care Network, Shelby, NC 28150-3934 Ph: (704) 480-9344 | Dr Kenneth Kyle Cloninger, MD 808 Schenck St, Shelby, NC 28150-3934 Ph: (704) 480-9344 |
News Archive
Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced that it has acquired the worldwide development and commercialization rights to the novel topical therapeutic for psoriasis and atopic dermatitis, PAP-1. Circassia acquired the rights to the proprietary molecule from Airmid Inc, for an undisclosed upfront sum plus milestone payments and royalties on future product sales.
Twenty per cent of hearing aid users in Norway use the equipment for only an hour each day. The reason is often poor fitting and inadequate support. Now all this could change.
Fox Chase Cancer Center's Office of Health Communications and Health Disparities (OHCHD) recently received a grant from the National Breast Cancer Foundation to fund community-based patient navigation services.
The European Commission has approved a personalized cellular therapy developed at the University of Pennsylvania's Abramson Cancer Center, making it the first chimeric antigen receptor (CAR) T cell therapy permitted for use in the European Union in two distinct indications.
Although mutations in a gene dubbed "the guardian of the genome" are widely recognized as being associated with more aggressive forms of cancer, researchers at the University of California, San Diego School of Medicine have found evidence suggesting that the deleterious health effects of the mutated gene may in large part be due to other genetic abnormalities, at least in squamous cell head and neck cancers.
› Verified 5 days ago
Dr. George Lee Bradley, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 615 S Dekalb St, Shelby, NC 28150 Phone: 704-480-1882 Fax: 704-480-1832 | |
Dr. Robert Sandborn Perkins, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 808 Schenck St, Cleco Medical Center Of Shelby, Shelby, NC 28150 Phone: 704-484-3647 Fax: 704-471-2727 | |
Keturah Chesbrough Bell, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 708 Mcbrayer Homestead Rd, Shelby, NC 28152 Phone: 980-487-2090 | |
Tracy Lee Phelps, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1124 N Washington St, Shelby, NC 28150 Phone: 980-487-1148 | |
Dr. Julia K Roos, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 520 N Dekalb St, Shelby, NC 28150 Phone: 704-484-8001 Fax: 704-484-2485 | |
Dr. Robert M Dorn, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 305 W College Ave, Shelby, NC 28152 Phone: 704-818-9200 |